| Date Filed | Type | Description |
| 12/22/2022 |
4
| Matkovits Theresa (Chief Development Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 625,000 options to buy
@ $0.53, valued at
$331.3k
|
|
| 12/22/2022 |
4
| Liu Hui (Chief Technology Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 625,000 options to buy
@ $0.53, valued at
$331.3k
|
|
| 12/22/2022 |
4
| Kucinski Keith A (CFO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 625,000 options to buy
@ $0.53, valued at
$331.3k
|
|
| 12/22/2022 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 1,988,300 options to buy
@ $0.53, valued at
$1.1M
|
|
| 12/22/2022 |
4
| Hoover Thomas (Chief Business Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 475,000 options to buy
@ $0.53, valued at
$251.8k
|
|
| 12/22/2022 |
4
| Ferguson James J. III (Chief Medical Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 625,000 options to buy
@ $0.53, valued at
$331.3k
|
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| WIKLER MATTHEW (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 142,657 options to buy
@ $0.7268, valued at
$103.7k
|
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| WIKLER MATTHEW (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 7,859 shares
@ $0 |
|
| 12/15/2021 |
4
| Jabbour Jerome D (President and CEO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 1,658,100 options to buy
@ $0.92, valued at
$1.5M
|
|
| 12/15/2021 |
4
| Kucinski Keith A (CFO) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.92, valued at
$460k
|
|
| 12/15/2021 |
4
| Hui Liu (Chief Technology Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.92, valued at
$253k
|
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Matkovits Theresa (Chief Development Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.92, valued at
$460k
|
|
| 12/15/2021 |
4
| Ferguson James J. III (Chief Medical Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 587,600 options to buy
@ $0.92, valued at
$540.6k
|
|
| 12/15/2021 |
4
| Hoover Thomas (Chief Business Officer) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 850,000 options to buy
@ $0.92, valued at
$782k
|
|
| 12/15/2021 |
3
| Hoover Thomas (Chief Business Officer) has filed a Form 3 on Matinas BioPharma Holdings, Inc. |
| 11/02/2021 |
4
| Giordano Natasha (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 90,882 options to buy
@ $1.12, valued at
$101.8k
|
|
| 11/02/2021 |
4
| WIKLER MATTHEW (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 90,882 options to buy
@ $1.12, valued at
$101.8k
|
|
| 11/02/2021 |
4
| Scibetta James S (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 90,882 options to buy
@ $1.12, valued at
$101.8k
|
|
| 11/02/2021 |
4
| CONRAD HERBERT J (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 90,882 options to buy
@ $1.12, valued at
$101.8k
|
|
| 11/02/2021 |
4
| Ende Eric J (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 90,882 options to buy
@ $1.12, valued at
$101.8k
|
|
| 11/02/2021 |
4
| Corzo Kathryn Penkus (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 181,763 options to buy
@ $1.12, valued at
$203.6k
|
|
| 11/02/2021 |
3
| Corzo Kathryn Penkus (Director) has filed a Form 3 on Matinas BioPharma Holdings, Inc. |
| 10/01/2021 |
4
| WIKLER MATTHEW (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 6,106 shares
@ $0 |
|
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| WIKLER MATTHEW (Director) has filed a Form 4 on Matinas BioPharma Holdings, Inc.|
Txns:
| Granted 10,244 shares
@ $0 |
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|